Dan-Andrei Waitman, MD, MPH

Sporadic, unsubstantiated side effects were reported in the mass media after a formulation change of levothyroxine tablets induced patients to monitor thyroid-stimulating hormone levels and to unnecessarily stop taking medication.

Prior authorization was successfully implemented in a managed care setting to obtain 100.0% performance of A1C testing in patients with diabetes treated with expensive drugs.

Simple restructuring of a computerized order form significantly reduced the number of laboratory tests suspected of being unnecessary or redundant.